Developing targeted strategies to modulate UCP2 for the treatment of sepsis is undoubtedly a therapeutic approach with great potential, based on the following rationale: (1) during sepsis, differential expression of UCP2 leads to distinct and even opposing biological effects. Here, UCP2 is linked to Sepsis.